Pharmaceutical Firm Installs 9.95 MW Solar
KDC Solar commenced commercial operations of its 9.95- MW solar panel system in New Jersey. The system will provide electricity to Eli Lilly and Company’s ImClone biopharmaceutical operations in Branchburg, NJ.
The new system will generate nearly 12.9 million kWh per year. It will provide the primary Lilly manufacturing facility at this location with about 45 percent of its annual electricity needs. KDC Solar developed, owns and will operate the solar panel system.
KDC Solar signed an engineering and construction contract for the installation of the solar project with The Whiting-Turner Contracting Company and SPI Solar. Whiting-Turner was the general contractor, and SPI Solar provided solar panel procurement and oversight.
The solar panel system uses 40,180 PV panels, 16 Advanced Energy Industries 500 kilowatt inverters and is ground-mounted across 43 acres of land owned by a subsidiary of KDC Solar.
- Migration to Mobile: The Evolution of EHS Management Tools
- 2015 Environmental Leader Product & Project Awards
- Improve Your Company's Environment and Energy Performance
- Mobility from the Plant Floor to the Store Door: Improve Safety, Accuracy and Productivity
- Solar Request for Proposal (RFP) Guide
- Case Study: Dassault Falcon Jet Taps Intelligent LED Lighting Solutions
- Gartner Magic Quadrant
- How to Thrive in Today's EHS Landscape
- Best Practices in Electricity Procurement
- Combined Heat and Power